Clinical Trials Directory

Trials / Completed

CompletedNCT04912752

Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression

Copy Number Variation in Migraine and Gene Expression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of Gaziantep · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Migraine is a common and possible hereditary disease. Copy number variation (CNV) is a phenomenon in which parts of the genome are repeated and the number of repeats in the genome varies between individuals in the human population.The CHRNA7 gene has a major role in the neuropsychiatric phenotypes observed in patients. The 15q13.3 gain/loss variation in this gene may be associated with migraine.

Detailed description

Migraine is a common neurological disorder. Although they have different genetic bases according to their types, cholinergic receptors after calcium channels play an important role in the clinic and genetics of the disease. Neuronal acetylcholine receptor subunit alpha-7, also known as nAChRα7, is a protein that in humans is encoded by the CHRNA7 gene.

Conditions

Interventions

TypeNameDescription
GENETICMigraine CNVCopy number variation effect on migraine disease

Timeline

Start date
2020-04-05
Primary completion
2020-12-10
Completion
2021-01-02
First posted
2021-06-03
Last updated
2021-06-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04912752. Inclusion in this directory is not an endorsement.